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Biomolecules, especially proteins, peptides, and DNA, whichfunction as the molecular building blocks of biological
systems, are of fundamental importance for creating future
biogeneration of electronic and photonic devices and sensors
in hybrid architectures.14 Their unique molecular capabilities in
self-assemblymake these molecules desired candidates for hybrid
applications at the nanobio interface (compared to available
synthetic approaches). In nanotechnology applications, great
attention has been paid to biohybrid nanomaterial systems to
discover new assembly techniques.59 In this context, the inter-
action of nanoparticles with proteins, peptides, and DNA has
been studied for innovative and robust biohybrid designs.1012
Colloidal semiconductor quantum dots (QDots), also known as
nanocrystals, have been utilized in several nano- and biotechnolo-
gical applications.13,14 Their attractive electronic and optical prop-
erties including size-tunable optical emission, high quantum yield,
and photostability enabled these nanoparticles to be exploited
in various photonic device platforms.15 In recent studies, for
example, capabilities of QDots have been demonstrated for white
light generation and tunability in color-conversion light-emitting
diodes.16,17With their unique and desirable properties QDots have
been one of the most widely studied classes of nanomaterial
systems for protein and peptide based systems.18 Quantum dot
labeled proteins and peptides promise to be useful as molecular
probes in many applications including cancer targeting,19,20 deter-
mination of toxins in food and environmental samples,21 and
detection and quantiﬁcation of pathogenic microorganisms in food
samples.22 Beyond sensitive biolabeling applications, in the past
decade, studies also showed that semiconductorQDots (e.g., CdTe
andCdSe) can be utilized in F€orster-type resonance energy transfer
(FRET) processes. Such nonradiative energy transfer directs
excitation energy from donor QDots to acceptor QDots in close
proximity.2325
QDots have been widely used in FRET processes in bio-
molecular systems and many successful applications were
demonstrated. In the work reported by Matussi et al., maltose
binding proteins labeled with Cy3 dye (emitting at 570 nm)
were conjugated to QDots emitting at 510 nm, and the
resulting energy transfer between the dye molecules and
quantum dots was probed. Upon binding the proteins changed
conformation to allow FRET.26 Similar studies were also
conducted for the targeted conjugation of QDots with proteins
without sacriﬁcing the protein functionality.27 In another study
QDotprotein bioconjugates were utilized in building protein
arrays for speciﬁc recognition of targeted antibodies and
elements, where FRET signal was used for robust detection
of proteinantigen molecule interaction.28,29 Quenching is
another phenomenon used as a signal from QDotprotein
bioconjugates. This was exploited to detect a drug molecule
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ABSTRACT: A bottom-up approach for constructing colloidal
semiconductor quantum dot (QDot) nanocomposites that
facilitate nonradiative F€orster-type resonance energy transfer
(FRET) using polyelectrolyte peptides was proposed and
realized. The electrostatic interaction of these polypeptides
with altering chain lengths was probed for thermodynamic,
structural, and morphological aspects. The resulting nanocom-
posite ﬁlm was successfully cut with the protease by digesting
the biomimetic peptide layer upon which the QDot assembly
was constructed. The ability to control photoluminescence
decay lifetime was demonstrated by proteolytic enzyme activity,
opening up new possibilities for biosensor applications.
KEYWORDS: Nanocomposites, quantum dots, polypeptides,
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named paraoxon, in the context of which a QDotprotein
based detector was proposed.30 FRET applications of QDot
bioconjugates were also integrated in microﬂudic systems; this
concept was introduced in a proof-of-concept study toward
detection of DNA, where QDot-functionalized oligomers were
successfully employed.31
To design and implement solid state devices using QDots, how-
ever, thin ﬁlm concept is essential. Thin ﬁlm approach allows for
forming nanostructures with ﬁlm thicknesses ranging from nanome-
ters tomicrometers. There are a number of diﬀerentmethods for thin
ﬁlm construction including spin coating32,33 and layer-by-layer (LbL)
assembly.34 InLbL assemblymolecules canbepiled up in a sequential
arrangement with desired spatial distribution. Because the number of
separation layers can control the distance between active layers, LbL
ﬁlm is a perfect architecture to study FRET applications.35
Layer-by-layer deposition of inorganic materials in biological
systems is common. Lustrin is a protein with polycationic
domains, managing formation of layer-by-layer assembly of
aragonite in mollusk shell,36,37 and similarly silicatein protein is
responsible for the formation and assembly of complex silica
structures in a diatom, Cylindrotheca fusiformis. Molecular char-
acterization of silicatein protein validated the existence of poly-
electrolyte peptide domains that are eﬀective in silica
formation.38 Similarly, prismatic asprich protein family is located
in the shell matrix of the mollusk shell and, through the
electrostatic calcium binding domain, this mediates the layer-
Figure 1. Isothermal titration calorimetry (ITC) curves for the peptide pairs: PLKC25PLE25 (A), PLKC100PLE25 (B), PLKC25PLE100 (C), and
PLKC100PLE100 (D). In the top graphs, the black solid line shows the actual experimental data of titration peaks for each sample. In the bottomgraphs, the
red solid line represents themodel ﬁtted to the experimental data to extractΔH,ΔS, andKeq, while the integrated peak areas are given in the black dotted line.
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by-layer deposition of calcium carbonate.39 The asprich protein
family contains high amounts of polycationic residues, and these
polyelectrolyte domains are assigned for the LbL assembly
of the inorganic calcium.40 The strength and robustness of the
layer-by-layer assembled biomineral matrices provides us with a
favorable model to construct LbL-assembled QDots for FRET
applications.
In this paper we proposed and demonstrated QDot nano-
composites constructed using polyelectrolyte peptides, poly-L-
lysine (PLKC), and poly-L-glutamic acid (PLE), with varying
chain lengths to stack QDots for FRET processes. First, we
characterized the binding and structural rearrangements of these
peptides upon their interactions with each other. After the
assembly of peptides, adsorption of donor CdTeQDots emitting
at 560 nmon the peptide layer was achieved and varying numbers
of peptide interlayers were subsequently formed, on top of which
acceptor CdTe QDots emitting at 640 nm were placed. Using a
quartz crystal microbalance, the change in ﬁlm thickness was
tracked upon deposition of sequential layers. The peptide ﬁlms
were also characterized using atomic force microscopy, for
comparison of all possible combinations of PLKC and PLE
(with varying chain lengths of 100 and 25). The peptide ﬁlm
combinations were tested for the energy transfer using both
steady-state and time-resolved photoluminescence spectroscopy.
For its superior ﬁlm quality, PLKC100PLE25 was studied for
assays with protease. Its nanocomposite ﬁlms with QDots were
successfully cut by digesting biomimetic peptide layers with the
protease. The proteolytic enzyme control of the acceptor life-
times in these QDotpeptide constructs was demonstrated.
Such peptide-mediated QDot solids are promising for novel
biologically controlled devices and sensors.
To form peptidic thin ﬁlms for the assembly of QDots, poly-L-
lysine and poly-L-glutamic acid were custom synthesized by
Alamanda Polymers (AL, USA), using solid-state peptide synth-
esis with a purity of 95%. The peptides were synthesized with
25mer and 100mer chain lengths; no further puriﬁcation was
made (see Supporting Information). To probe the eﬀect of
diﬀerent peptide chain lengths on the assembly of the peptide
ﬁlm, the thermodynamics of interaction between the peptides
was investigated. The binding of positively charged PLKC
molecules and negatively charged PLE molecules was monitored
by using an isothermal titration calorimetry (ITC), ITC200,
from Microcal (GE Healthcare, Austria), under continuous
stirring at 1000 rpm with thermostating at 25 C. The binding
isotherms were ﬁt to a two-site binding model to extract the
thermodynamic parameters, where the initial points were dis-
carded to avoid possible errors caused by the initial diﬀusion of
injectant in each isotherm. The data were analyzed and ﬁt to the
model using the software packageOrigin 7 supplied with ITC200
(see Supporting Information). PLKC molecules, which have
either 25 or 100 amino acid (aa) chain lengths, were titrated
against the negatively charged PLE molecules, again with the
chain lengths of 25 or 100 aa, in all possible combinations. The
areas under the thermodynamic titration peaks were integrated
and the thermodynamic parameters were calculated by ﬁtting
these peak areas to the interaction model in Origin 7. Figure 1
shows experimental thermodynamic titration curves (in black),
along with their data ﬁttings (in red), and Table 1 lists the
thermodynamic constants (enthalpy changes, entropy changes,
and binding equilibrium constants) obtained from these ITC
experiments for each of the peptide pairs.
The peptide chain length controls the binding energy and
aﬃnity through the functional side chains. However, given a
peptide, there is no simple linear relationship.41 In this case here,
we have concatamers of the same amino acid, for which we
expect an increased binding aﬃnity with the increasing peptide
chain length. In our analysis, the interaction of PLKC100
PLE100 was found to have the highest binding energy, while
PLKC25PLE25 has the lowest binding aﬃnity among all peptide
combinations. The other peptide combinations, PLKC100
PLE25 and PLKC25PLE100, expectedly exhibit their binding
energies between the highest and lowest levels. The interaction of
each peptide has a positive enthalpy change, which indicates that
the interaction of the peptides is an endothermic process.
A large entropy change with a positive sign is also notable for
the interactions. The positive entropy may arise due to the loss
of the structured water shell formed around the peptides upon
peptidepeptide interaction. Peptides are surrounded by a
water shell in buﬀer, and the charge of peptides and salt ions
rules the formation of a water shell around the peptide mol-
ecules. However, when two oppositely charged peptides are
interacting, the water in the contact surface of the peptides is
repelled. This causes the rearrangement of contact sides of the
peptides. This is generally attributed to the electrostatic inter-
action and burial of the polar groups during proteinprotein
interaction.4244 Compared to the other peptide pairs, the
PLKC100PLE100 pair features the highest equilibrium binding
constant, which is∼6.9 106 M1, and, surprisingly, the change
in aﬃnity constant of the peptide pairs does not follow a trend.
PLKC100PLE25 and PLKC25PLE100 do not exhibit a
similar level of binding capability, with the binding constant of
PLKC100PLE25 (∼3.3  105 M1) being more than 4-fold
better than that of PLKC25PLE100 (∼7.9 104 M1). It was
also unexpected that the shortest chain combination leads to an
intermediate-level interaction constant of ∼2.2  105 M1,
which is larger than PLKC25PLE100 and smaller than
PLKC100PLE25.
Next, the structural investigation of the peptide pairs is
important because the structure of these peptides directs their
binding aﬃnity during ﬁlm formation on a given surface.45 Here
the secondary structures of the peptides were investigated using
circular dichroism (CD) spectroscopy presented in Figure 2.
CD measurements were taken using peptides with 25 μM
concentrations dissolved in phosphate buﬀer (pH 7.4) in a quartz
cuvette with 1mmpath length (see Supporting Information). The
data were deconvoluted using a package program called CDPro.46
The program uses a large protein secondary structure database as a
reference set. By employing a least-squares curve ﬁtting algorithm,
the program calculates the amount of the secondary structure in a
given sample on the basis of the chosen reference set. It is thus
Table 1. Thermodynamic Constants Gathered from
Isothermal Titration Calorimetry (ITC) Experiments for
Each of the Peptide Pairsa
peptide couple ΔH (kcal/mol)
ΔS (cal mol1
K1) Keq (M
1)
PLKC 100PLE 100 24.0( 0.5 113.0 (6.9 ( 1.5)  106
PLKC 100PLE 25 10.0( 0.8 58.6 (3.3 ( 1.4)  105
PLKC 25PLE 100 12.0( 0.6 62.9 (7.9 ( 1.4)  104
PLKC 25PLE25 5.7( 0.2 46.5 (2.2 ( 0.3)  105
aThe ITC data were analyzed and ﬁt to the model using Origin 7
supplied with ITC200.
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important to use the largest and most appropriate reference
set.46,47 The results from these runs using the largest available
reference set are summarized in Table 2.
For the secondary structure analyses, we investigated three
diﬀerent cases in particular: individual peptides, positively and
negatively charged peptide pairs interacting each other, and
positively charged peptides interacting with negatively charged
QDots. First, the secondary structures of each individual peptide
were determined. In Table 2, these results show that the
percentage of unordered structure overwhelms for positively
charged PLKC100 and PLKC25, and the beta strand type
secondary structure seems to be dominating for the negatively
charged PLE100 and PLE25, possibly also triggering the forma-
tion of the β-sheet structures. Except for PLKC25, the helical
content of the peptides is low, which may be a good sign for
peptidepeptide interactions because during formation of the
peptide ﬁlm on the silica substrate sheetlike structures are more
desirable for exposing the binding sites to immobilize QDots.
In the second case, we examined probable secondary struc-
tures of the peptide pairs forming as a result of interactions
between them. The peptides were mixed at the same concentra-
tions, following which their circular dichroism data was recorded.
We observed for all combinations of the peptide complexes that
they become more structured when mixed compared to the
individual cases. PLKC100 and PLKC25, each of which pos-
sesses alone an almost 50% unordered type secondary structure,
become richer in the beta strand after mixed with PLE peptides.
Depending on the increased beta strand content of PLKC after
interacting with PLE, it is expected that peptide pairs may
transform more into sheetlike structures after their assembly
on the silica surface, which is a common case observed for other
polypeptide ﬁlms.48
Upon adsorption of the peptide ﬁlm on a solid surface, a
possible rearrangement of the peptide structure is contemplated.
In solution, polypeptides mostly exhibit an unordered structure
in their native form, which is also the case observed for the
peptides we used in this study. This is due to the absence of
intermolecular interactions and formation of a stable state. This
observation is also common for short peptides screened from
phage display libraries for their aﬃnity to bind inorganic surfaces
and mineral-forming peptides isolated from organisms.49 This is
a good indicator that this unordered structure of the peptides in
native form possibly increases the binding aﬃnity of the peptides
onto the solid surface.50,51 When the peptides are adsorbed on a
solid surface, the core sites for peptide binding are immobilized.
This can restrict the free movement of the peptides, and it has
been reported that such polypeptide ﬁlms (e.g., polylysine), as a
result, tend to form a sheetlike structure on the solid surface.52
Compared to the peptidepeptide interactions, the interac-
tion of peptides with QDots is a completely diﬀerent situation.
During the LbL assembly, the negatively charged CdTe QDots
will be positioned against the positively charged PLKC peptides
through an electrostatic interaction. In the third case of the
secondary structure analyses, to inspect and understand the
structural circumstances of these peptides after their interaction
with QDots, we extended our observations for the CD char-
acterization to PLKC peptides incubated with CdTe QDots. As a
result of their interaction with CdTe QDots, PLKC peptides
were found to have enhanced their beta strand type secondary
structure elements (reaching a percentage of 44% in the case of
PLKC25 and 38% in the case of PLKC100). Sheetlike arrange-
ment of these peptides on CdTe QDots surface indicates the
possible orientation of the peptides after adsorption.
After the initial characterization of the peptidepeptide and
peptideQDot interactions, the peptide ﬁlms with/without
Figure 2. Circular dichroism (CD) spectra for individual peptides (A),
peptide pairs interacting each other (B), and peptides interacting with
CdTe QDots (C). CDPro program-based secondary structure database
was used to ﬁt the experimental data (given in black dotted line) using
the least-squares curve ﬁtting (shown in red solid line). Each sample is
labeled on the data line.
Table 2. Secondary Structure Elements of Individual
Peptides, Peptide Pairs, and Peptides Interacting with CdTe
QDots. a
secondary structure elements
peptides helical strand turn unordered
PLKC100 0.06 0.23 0.20 0.51
PLKC25 0.17 0.15 0.24 0.45
PLE100 0.04 0.42 0.20 0.35
PLE25 0.04 0.41 0.20 0.35
PLKC100PLE100 0.04 0.41 0.21 0.34
PLKC100PLE25 0.04 0.42 0.22 0.33
PLKC25PLE100 0.04 0.40 0.21 0.35
PLKC25PLE25 0.03 0.44 0.20 0.33
PLKC100QDot @ 640 nm 0.04 0.38 0.20 0.38
PLKC25QDot @ 640 nm 0.03 0.44 0.20 0.33
aThe ratios were calculated using CDPro spectrum analysis program.
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CdTe QDots were formed through LbL assembly using a
computer-controlled dip coater (Nima Technology, U.K.) oper-
ated at a constant dipping and pulling speed. The surface of the
silica substrate was preprocessed to increase the negative surface
charge density. First a positively charged peptide (PLKC100 or
PLKC25) was assembled on the negatively charged silica surface
and a negatively charged peptide layer (PLE100 or PLE25) was
subsequently laid down, following which another layer of the
positively charged peptide was coated. CdTe QDots were then
assembled on top of the last positively charged peptide layer.
These QDots contain a negative charge on their outer shell due
to the thioglycolic acid introduced during their colloidal synth-
esis (see Supporting Information).
To acquire an idea about the morphology of the resulting
peptide-mediated QDot nanocomposites, the ﬁlms were ana-
lyzed using atomic force microscopy (AFM). In Figure 3, the
AFM images reﬂect the assembly and morphology of these
QDotpeptide nanocomposite ﬁlms on the silica surface, for
which details of the sample preparation and measurements can
be found in the Supporting Information. The surface coverages
of these ﬁlms calculated using an image-processing program
called ImageJ are also provided (in percentages) in Figure 3.
Although the PLKC100PLE100 pair exhibited the highest
binding energy, the AFM data revealed that this peptide pair
did not form a homogeneous and continuous ﬁlm but instead
produced aggregates around QDots that are randomly dispersed.
As a result, this nanocomposite ﬁlm was not spread homoge-
nously on the surface, yielding the lowest surface coverage of 24%
compared to the other ﬁlms. The PLKC25PLE25 pair formed a
better ﬁlm, with a surface coverage of 40%, compared to
PLKC100PLE100. However, since their peptide chains are
shorter, the formed ﬁlm consists of islands without a network,
which is not a desirable feature for thin-ﬁlm device applications.
In the case of PLKC25PLE100, the nanocomposite ﬁlm
also formed islands, which are larger than those of PLKC25
PLE25 and covered the surface at a ratio of 42%, perform-
ing slightly better than the PLKC25PLE25 pair. Finally, the
best ﬁlm formation was attained by the PLKC100PLE25 pair,
outperforming all the rest by far. This nanocomposite construct
with QDots embedded in it was formed in a continuous and
homogeneous ﬁlm on the surface and led to an acceptable surface
coverage of 80%, which suﬃces for most device applications. The
resulting PLKC100PLE25 ﬁlm contains small spherical parti-
cle-like formations, which are interconnected to each other,
extending into almost a fully continuous ﬁlm surface. This
molecular architecture of PLKC100PLE25-assisted CdTe
QDot nanocomposite gives us an insight on how to build a
robust and homogeneous peptide-mediated ﬁlm on a solid
surface. Subsequently, we analyzed the F€orster-type nonradiative
energy transfer in these nanocomposite systems, where we
focused on the ﬁlm homogeneity of the nanocomposite con-
structs as a preferential objective important for obtaining repro-
ducible FRET experiments with controlled FRET eﬃciency.
Altogether based on the thermodynamic, structural and
morphological assessments of these peptide-mediated nanocom-
posite ﬁlms, the sheetlike structure of peptides is potentially
expected to lead to ﬁbril formation on the solid substrate surface,
which has also been suggested in previous studies with amyloid
forming peptides.5356 However, due to the chain lengths and
strength of the interactions, this does not have to be necessarily
always the dominating case. For example, in the case of the
longest chain combination, PLKC100PLE100 formed aggre-
gates instead of ﬁbrils. Such aggregates are considered to prevent
the formation of continuous ﬁlm structures and induce formation
of discrete frames of peptide islands. On the other extreme, for
the shortest chain combination, PLKC25PLE25 did not form
aggregates, but lacked a continuous ﬁlm formation. This is
attributed to the short chain lengths of the peptide pair, which
seem to be insuﬃcient to enable the QDotpeptide complex to
form a continuous ﬁlm. Among the rest of the peptide pairs, in
Figure 3. Atomic force microscopy (AFM) images of the peptide-mediated CdTe quantum dot nanocomposite ﬁlms using diﬀerent peptide pairs:
PLKC25PLE25 (A), PLKC100PLE25 (B), PLKC25PLE100 (C), and PLKC100PLE100 (D). Black lines indicate the proﬁle lines across the
assemblies. The surface fraction images, shown in black and white, represent the surface coverage of the peptide ﬁlms. The calculated surface coverage of
the peptide ﬁlms is provided below the processed images. The AFM images are taken from a 5 μm  5 μm area.
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accordance with the ranking of their binding strengths
(Keq(PLKC100PLE25) . Keq(PLKC25PLE100)), PLKC-
100PLE25 complex allowed for an exceedingly better ﬁlm
formation with respect to the case of PLKC25PLE100. Here
PLKC100PLE25 is considered to possibly form a sheetlike
structure in agreement with their secondary structure, which has
been reported to be found in ﬁbril-like biological macromole-
cular architectures, like amyloidal proteins on solid surfaces.57,58
The AFM image shown for PLKC100PLE25 in Figure 3 also
supports the formation of ﬁbril-like extended structures with a
homogeneous distribution.
As a special case, we investigated the layer-by-layer ﬁlm
formation in real time using PLKC100-PLE25 peptide pair. With
a quartz crystal microbalance with dissipation monitoring
(QCM-D) from Q-Sense (Frolunda, Sweden), we tracked the
LbL ﬁlm growth for each layer, and determined the thickness of
each ﬁlm layer using a viscoelastic modeling (see Supporting
Information). The assembly plot is depicted in Figure 4, where
each step of the assembly is labeled. Here Figure 4A shows the
dissipation variation (given in green line) and the frequency shift
(given in red line), corresponding to the change in bound mass
over time during the LbL assembly process, and Figure 4B
provides the thickness of each layer calculated using the raw
data. These experimental data were ﬁtted using the Voight-based
viscoelastic model.59,60 In this model the frequency and dissipa-
tion changes are related to the formed ﬁlm thickness, density
of the formed ﬁlm, and viscosity of the ﬁlm on the quartz
resonator.61 The ﬁlm thickness of each layer is obtained by
solving the Voigt model at diﬀerent oscillation frequencies
(overtones) of the QCM-D using Q-Tools (version 3.0.7), the
software supplied along with the equipment. In Figure 4A, the
violet line represents the ﬁtted Voight model estimation to the
dissipation data (in green line), with its resulting ﬁlm thickness
extraction for each layer shown in Figure 4B.
The PLKC100 layer adsorbed on the silica surface has a ﬁlm
thickness of 1 nm. Initially, upon adsorption of PLKC100, a large
change in the dissipation is observed in Figure 4A. However, this
shift decreases dramatically after washing with the buﬀer. This
decrease may result not only from the removal of loosely bound
peptides but also from the loss of water held by the peptide in
solution. The next layer is CdTe QDots coated on PLKC100
layer by strongly binding them through electrostatic interaction
with the surface-bound peptides. Subsequently a series of peptide
ﬁlms are laid down, here PLKC100PLE25PLKC100, to
make a 3 nm thick peptide interlayer between the bottom and
top QDot layers in the ﬁlm. This separation is suﬃcient for
nonradiative energy transfer. Finally, on the top is assembled a
CdTe QDot layer. Despite the high dissipation alterations
observed for the peptide layers, it was found out that the
dissipation change is low for CdTe QDot layers during the
rinsing phase. This observation is an indicator possibly for the
formation of tight QDot ﬁlms.
Upon study of the architecture of peptide-mediated CdTe
QDot nanocomposite ﬁlms and morphology of the resulting
ﬁlms as discussed above, the molecular constructs of donor and
acceptor CdTe QDots were made using polypeptides via LbL
technique. As sketched in the schematics of Figure 4B, ﬁrst the
negatively charged silica layer was decorated with positively
charged PLKC100, on top of which the donor QDots emitting
at a peak emission wavelength of 560 nm were assembled. After
placing the ﬁrst CdTe QDot layer serving as the donor, a
number of repeating peptide layers (alternating series of
PLKC100 and PLE25) were added before the assembly of the
last CdTe QDot layer serving as the acceptor on the very top.
Such a repetitive use of PLKC and PLE ﬁlms in an alternating
order enables us to create an increasing number of peptide
interlayers between the donoracceptor CdTe QDot ﬁlms.
During the LbL assembly, as shown in Figure 4, each assembly
step was followed by an intense washing step to remove
nonreacted species from the ﬁlm surface and achieve a robust
and reliable peptidic ﬁlm.
For these nanocomposite constructs, we ﬁrst inspected the
steady-state photoluminescence (PL) spectra of the peptide ﬁlms
involving the donor alone, the acceptor alone, and the donor
acceptor pair. Figure 5 shows the PL spectra taken using a Varian
Cary Eclipse ﬂuorescence spectrophotometer, which indicate a
clear ﬁgure of energy transfer. In Figure 5 three cases are
compared: Figure 5A shows the photoluminescence from the
donor CdTe QDots that emit at 560 nm, while Figure 5B gives
the PL from the acceptor CdTe QDots emitting at 640 nm. On
the other hand, Figure 5C presents the PL of the donor and
acceptor QDot pair together. Figure 5C suggests FRET-based
energy transfer from the donor QDots to the acceptor QDots,
when compared to Figure 5A,B. In Figure 5C, there is a clear
increase observed in the emission intensity of the acceptor
QDots (i.e., emission enhancement), whereas there is a clear
Figure 4. Quartz crystal microbalance with dissipation monitoring
(QCM-D), where the red line shows the frequency shift and the green
line gives the change in the dissipation upon formation of each layer, and
the violet line presents the result of the viscoelastic model ﬁtted to the
dissipation data (A). Calculated ﬁlm thickness from the viscoelastic
model for each one of the layer formations during the LbL assembly
process (B).
1536 dx.doi.org/10.1021/nl104295b |Nano Lett. 2011, 11, 1530–1539
Nano Letters LETTER
decrease observed in the emission intensity of the donor QDots
(i.e., emission suppression). This observation is common for
FRET-type interaction between these QDots.
Subsequently we took time-resolved photoluminescence
(TRPL) measurements, shown in Figure 6, using a time-corre-
lated photon counting setup (from PicoQuant GmbH, Germany)
(see Supporting Information). These were recorded for the
QDotpeptide nanocomposite ﬁlm that contains both the
acceptor and donor QDot layers (before and after the pro-
tease-based digestion of the peptidic ﬁlm) and the one that
contains only the acceptor QDots in the nanocomposite con-
struct as a reference measurement, all at the acceptor emission
wavelength of 640 nm. Also, the protease digestion process of the
peptide nanocomposite was presented in the schematics evolving
from curves A to D of Figure 6. For the protease cut sketched in
Figure 6B, the nanocomposite ﬁlm was immersed into a protease
solution (from bovine pancreas Type I, Sigma, St Louis, MO,
USA) prepared in phosphate buﬀer (pH 7.4) and incubated for 4
min, and the protease was washed oﬀ from the surface to take the
measurement presented in Figure 6C. The TRPL measurements
are compared for three cases: In Figure 6D is the photolumines-
cence decay measurement of the acceptor CdTe QDots alone in
the ﬁlm as a control group, while in Figure 6A is the lifetime
measurement of the CdTeQDot acceptors in the presence of the
donor CdTe QDots in the ﬁlm. The acceptor lifetime was found
to be longer (because of a slower photoluminescence decay) in
the presence of the donors in the ﬁlm through FRET-based
energy feeding compared to the control group. After the protease
treatment, however, the lifetime measurement of the acceptor
CdTe QDots in the ﬁlm given in Figure 6C reveals that the
acceptor lifetime is shortened (due to a faster photoluminescence
decay with respect to Figure 6A) toward the reference level of the
acceptor alone.
The collected TRPL data were ﬁt to a biexponential decay
model, which is common for this type of QDot,62,63 with a χ2
error close to unity to calculate photon decay lifetimes, using
the PicoQuant software supplied along with the instrument,
FluoFit. The data ﬁt yields intensity-weighted lifetimes of the
acceptor and donor QDots summarized in Table 3. Subtracting
the ratio of the donor lifetime in the presence and absence of
the acceptors from unity, FRET eﬃciency (ηFRET) was com-
puted for each of the nanocomposite ﬁlms. The lifetime
analysis suggests that the PLKC100PLE25 pair keeps the
acceptor and donor QDots close enough for the FRET process
with a maximum acceptor lifetime of 1.27 ns and a correspond-
ing ηFRET of∼40%, which is a reasonable value for this type of
QDot. The PLKC100PLE25 nanocomposite ﬁlm, which is
considered to provide the best energy transfer case by a notable
increase in the acceptor lifetime thanks to the ﬁlm quality (ﬁlm
homogeneity and reliability), was therefore chosen to further
study enzymatic control of the energy transfer with varying
peptide interlayer spacings.
The eﬀect of separation between the donor and acceptor
CdTe QDot layers was next tested by varying the number of
Figure 6. Time-resolved photoluminescence (TRPL) of CdTe QDot
donoracceptor pair with FRET process (A), CdTe QDot do-
noracceptor pair after addition of the protease (B), TRPL of CdTe
QDot donoracceptor pair after cleavage of the peptide ﬁlm (C), and
TRPL of CdTeQDot acceptors only (D). The dotted lines are the actual
experimental data, while the solid lines are the model ﬁt to the time-
resolved photoluminescence data using a biexponential decay model.
Figure 5. Steady-state photoluminescence (PL) of individual CdTe
QDots emitting at 560 nm (the donor alone) assembled in the peptide
ﬁlm (A), steady-state PL of individual CdTe QDots emitting at 640 nm
(the acceptor alone) assembled in the peptide ﬁlm (B), and steady-state
PL collectively from both CdTe QDots emitting at 560 nm and those
emitting at 640 nm (the donoracceptor pair) in the same peptide ﬁlm,
showing the strong modiﬁcation in the PL intensity of these QDots
through FRET (C).
Table 3. QDot Donor and Acceptor Lifetimes, Their Decay Rates, and FRET Eﬃciencies for CdTeQDots Embedded in Diﬀerent
Peptide Films, along with χ2 Error Limits in Their Corresponding Lifetime Analysis
peptides τacc (ns) τdonor (ns) acceptor decay rate (ns
1) donor decay rate (ns1) ηFRET χ
2
single QDots 0.45 0.47 2.20 3.64 1.4
PLKC100PLE100 0.67 0.19 1.49 8.10 0.58 1.3
PLKC100PLE25 1.27 0.27 0.78 5.81 0.40 1.1
PLKC25PLE100 0.90 0.24 1.11 6.18 0.47 1.3
PLKC25PLE25 0.75 0.30 1.32 5.34 0.35 1.4
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repeating peptide interlayers (ranging from three to nine mono-
layers) between the acceptor and donor layers. Here, up to nine
monolayers of interlayer peptides, we were not able to observe a
noticeable change in the acceptor lifetimes listed in Table 4. This
may be due to the formation of sheetlike structures and strong
interaction between the peptides creating a denser and thinner
ﬁlm. If these sheetlike structures were not formed, aggregates
would have instead been formed in the ﬁlm, which could
otherwise have caused a signiﬁcant reduction in the energy
transfer rates due to substantially increased separation between
the interacting CdTe QDots.
Here since we utilize a peptide-regulated nanocomposite ﬁlm
formation, we can opportunely make use of the advantage to
mimic the natural process of biological molecules. In biosystems
unwanted proteins and peptides are cleaved by proteases, which
eﬀectively serve as a protein scissor, enabling the destruction of
poorly folded or contaminated proteins. This approach in nature
ﬁts our aim to cut the peptide ﬁlm between CdTe QDot layers.
Figure 7 presents the TRPL experiments for diﬀerent numbers of
the peptide interlayers before and after the protease activity,
along with the reference measurement of the acceptors alone.
Also, Table 4 shows the lifetimes calculated from these TRPL
experiments (for diﬀerent numbers of the peptide interlayers), all
of which exhibit a strong change in the lifetime of the acceptor
QDots before and after the protease cut. Upon the enzymatic
cleavage of peptides, the peptide ﬁlm is destructed (see Support-
ing Information). This causes CdTe quantum dots embedded
into the peptide ﬁlms to be separated from each other. The time-
resolved data shown in Figure 7 indicate a faster photolumines-
cence decay of the acceptor QDots after the protease attack,
which corresponds to a reduced energy transfer between the
donors and acceptors. This observation supports cleavage of the
peptide layers, thereby removal and separation of some of the
donor molecules from the ﬁlm. In the literature a similar
approach was used for quenching peptide-linked QDots in
solution by other research groups, where the energy transfer
was studied using PL measurements, requiring a careful char-
acterization for a quantitative analysis.64 Here, the advantage of
using the protease cut for the ﬁlm-based structures is that the
ability to control the lifetime of ﬂuorescent nanomaterial con-
structs based on FRET process by proteolytic enzyme activity
allows us to exploit the idea for possible biosensor or photonic
device fabrication.
In conclusion, we designed and implemented a biomimetic
LbL model to enable and control FRET process between QDots
using polypeptides. In this context, two important points were
considered with the highest priority, ﬁrst to create a peptide-
mediated LbL assembly of QDots in a nanocomposite construct
with FRET interaction and second to devise a biomimetic way to
Table 4. Change in the Acceptor Lifetime of CdTe QDots
Embedded in PLKC100PLE25 Peptidic Filma
no. of monolayers τacc (ns) acceptor decay rate (ns
1) χ2
3 L 1.96 0.50 1.1
3 L-cut 1.16 0.85 1.2
7 L 1.96 0.51 1.2
7 L-cut 0.80 1.25 1.2
9 L 1.84 0.54 1.2
9 L-cut 1.30 0.76 1.1
aThe “cut” refers to the acceptor lifetime after the protease attack.
Figure 7. Time-resolved photoluminescence (TRPL) before and after the protease-based cleavage of the nanocomposite ﬁlms for varying interlayer
ﬁlm thicknesses, with three monolayers of peptide interlayer (A), with ﬁve monolayers of peptide interlayer (B), with seven monolayers of peptide
interlayer (C), and nine monolayers of peptide interlayer (D). For comparison the cases before and after the protease attack are included along with the
reference measurement of the acceptors alone.
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control FRET between QDots. At ﬁrst place the formulation of a
suitable peptide-assisted QDot ﬁlm using the right pairing of
peptides was important. The chain length of peptides, combined
with their binding capability and secondary structure elements,
controls the morphological properties of the resulting construct.
In a direct way these contribute to the determination of ﬁlm
quality. Utilizing this idea, we probed the structural features and
binding aﬃnity of the peptide pairs and demonstrated that a
strong interaction is not the key for a good ﬁlm quality alone.
Thermodynamic analysis of the positively and negatively charged
peptides with diﬀerent chain lengths yielded TΔS values that
are favored during polyelectrolyte peptide interaction. There-
fore, a lower entropy system should be chosen with a strong
enough binding aﬃnity, which points to the pair of PLKC100
PLE25. We supported these ﬁndings from the morphology
analysis of the peptide ﬁlms, where we observed the most
homogeneous ﬁlm using PLKC100PLE25, into which CdTe
QDots were also successfully embedded without aggregate
formation.
One of the strong motivations for embedding nanocrystals
into a peptide-regulated ﬁlm is to utilize the tools of biochemistry
to control FRET eﬀect. With use of protease the peptide layer
was cleaved in a controlled manner. So not only the demonstra-
tion of FRET control was achieved by such a biochemical
process, but also a possible sensor for an enzymatic activity was
proposed in the form of a functional peptidic ﬁlm, which proves
to be easy and versatile to use. In currently available, typical
ﬂuorescence-based biosensing systems, read-out data rely on the
level of optical intensity (thus the collection and counting of
emitted photons) and need to be normalized with the greatest
care for a reliable quantitative characterization. On the other
hand, in our approach, instead of optical intensity levels, the
emission kinetics is monitored and photoluminescence decay
lifetimes are measured. This leads to a more robust detection,
decreasing the possibility of false signal detection, because the
changes in the emission kinetics can be correctly measured,
despite variations in the optical intensity levels. This approach
can be extended by introducing speciﬁc protease cleavage sites on
polypeptide chains for biosensor applications. Through introdu-
cing multiple binding sites for diﬀerent target molecules, FRET
may be controlled and various nanocomposite-based peptidic
ﬁlm biosensors can be devised potentially for a wide range of
applications in biological and medical sciences. Also, it could be
possible tomake sensor arrays using LbL assembled peptide ﬁlms
to detect diﬀerent types of proteases (or other targets) in a
mixture such as blood samples at the same time. By transfer of
this approach to an optoelectronic system, a biocontrolled
optical signal transduction can be envisioned. Such peptide-
based QDot nanocomposite constructs with FRET interaction
promise a wide range of applicability in both biological and
physical sciences.
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